Daiichi Sankyo Company, Limited

4568.T
Drug Manufacturers - General
2026/08/21 Updated
Market Cap: $32.8B (¥5.2T)
Stock Price: $18.04 (¥2,868)
Exchange Rate: 1 USD = ¥158.98

【Daiichi Sankyo】Full-Year 2026 Earnings Revision | Loss Due to Supply Plan Revisions

Daiichi Sankyo has revised its consolidated earnings forecast for the fiscal year ending March 2026 due to a review of its product supply plan, expecting losses. Revenue has been revised downward to approximately ¥21.23 trillion, and operating profit to approximately ¥2.29 billion.

Importance:
Page Updated: July 12, 2026
IR Disclosure Date: May 8, 2026

Key Figures

  • Sales Revenue: 2,123,000 million yen (Compared to previous forecast +1.1%)
  • Operating Profit: 229,000 million yen (Compared to previous forecast -31.6%)
  • Net Income Attributable to Owners of Parent: 260,000 million yen (Compared to previous forecast -9.7%)

AI要約

Performance Overview

Daiichi Sankyo has revised its consolidated earnings forecast for the fiscal year ending March 2026 due to a review of its product supply plan. While sales have increased to approximately ¥2.123 trillion, operating profit has been significantly revised downward to approximately ¥22.9 billion, with a projected loss. The main reasons are the review of supply capacity in the ADC business and impairments related to capital investments, leading to compensation costs. These factors have substantially impacted the outlooks for operating profit and net income.

Future Outlook and Impact

The revision of the supply plan will result in short-term losses, but medium- to long-term strategies involve redesigning business operations and optimizing supply systems. Investors should understand the temporary downside risks to earnings while focusing on future recovery and growth strategies. Notably, the review and suspension of capital investments in the ADC business may lead to structural transformations in the company's future business model.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Daiichi Sankyo Company Limited

Company overview · Stock price · Financial data · All IR

View company page →